A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Cynthia McLaughlin
| Share Statistics | RAPH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $30.5 | $463.0 | 13% |
|
| Shares Out (Mil) | 20.2 | 42.7 | 31% |
|
| Institutional Ownership | na | 82.2% | na |
|
| Float (Mil) | na | 44.3 | na |
|
| Beta | 1.90 | 0.73 | 90% |
|
| Avg Daily Volume (000s) | 0 | 344 | 0% |
|
| Price Change (52-week) |
na | 54.1% | na |
|
| Growth | RAPH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.1% | na |
|
| Net Income (5yr) | (13.2%) | (2.4%) | 27% |
|
| EPS (5yr) | 3.1% | 14.9% | 36 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 0.0% | (15.1%) | 64% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | RAPH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $416 | na |
|
| Net Income (TTM) (Mil) | ($1) | ($11) | 37% |
|
| EPS (TTM) | ($0.049) | ($0.700) | 37% |
|
| Operating Cash Flow (TTM) (Mil) | $0 | ($7) | 32% |
|
| Net Cash Flow (TTM) (Mil) | na | $6 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 0% |
|
| Enterprise Value (Q1) (Mil) | $28 | $493 | 13% |
|
| Valuation | RAPH | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.15 | na |
|
| P/E | na | 17.3 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | RAPH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 3.2% | na |
|
| ROA | na | (22.2%) | na |
|
| ROE | 66.8% | (21.0%) | 94% |
|
| Liabilities to Assets | na | 32.3% | na |
|
| F-Score | 1 | 3 | 1% |
|
Raphael Pharmaceutical Inc. did not pass any screens on 10/19/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
